Skip to main content

Advertisement

ADVERTISEMENT

Pain Management

News
02/01/2024

Tom Valentino

Tom Valentino
After announcing positive results in its Phase 3 program for its selective NaV1.8 inhibitor that was developed as an alternative to opioids for treating moderate-to-severe acute pain, Vertex Pharmaceuticals plans to submit its NDA application...
After announcing positive results in its Phase 3 program for its selective NaV1.8 inhibitor that was developed as an alternative to opioids for treating moderate-to-severe acute pain, Vertex Pharmaceuticals plans to submit its NDA application...
After announcing positive...
02/01/2024
Addiction Professional
News
01/15/2024
Tom Valentino, Digital Managing Editor
Findings from a recent study conducted by researchers at the Medical University of South Carolina suggest that N-acetylcysteine (NAC)—a drug already approved by the US Food and Drug Administration—may help decrease surgery patients’ pain...
Findings from a recent study conducted by researchers at the Medical University of South Carolina suggest that N-acetylcysteine (NAC)—a drug already approved by the US Food and Drug Administration—may help decrease surgery patients’ pain...
Findings from a recent study...
01/15/2024
Addiction Professional
News
12/27/2023
Tom Valentino, Digital Managing Editor
While prescribing of opioid-containing pain relief medications for surgery patients has declined over the past 7 years, a recent study of pharmacy data by researchers at the University of Michigan shows that decrease has slowed since 2020.
While prescribing of opioid-containing pain relief medications for surgery patients has declined over the past 7 years, a recent study of pharmacy data by researchers at the University of Michigan shows that decrease has slowed since 2020.
While prescribing of...
12/27/2023
Addiction Professional
veteran
News
07/24/2023
Tom Valentino, Digital Managing Editor
In a small study of patients with severe post-traumatic stress disorder, MDMA-assisted therapy was found to significantly reduce chronic pain scores among medium- and high-pain subgroups.
In a small study of patients with severe post-traumatic stress disorder, MDMA-assisted therapy was found to significantly reduce chronic pain scores among medium- and high-pain subgroups.
In a small study of patients...
07/24/2023
Psych Congress Network
News
07/21/2023
Tom Valentino, Digital Managing Editor
New opioid use by older adults with dementia has been associated with an 11-times higher risk within the first 2 weeks of initiating opioid use, according to a study released at the Alzheimer’s Association International Conference in...
New opioid use by older adults with dementia has been associated with an 11-times higher risk within the first 2 weeks of initiating opioid use, according to a study released at the Alzheimer’s Association International Conference in...
New opioid use by older adults...
07/21/2023
Addiction Professional
News
01/10/2023
Tom Valentino, Digital Managing Editor
A 3-day limit on opioid prescriptions to treat surgical pain reduced the number of patients who became chronic opioid users without compromising pain relief or recovery, according to a recent study at Roswell Park Comprehensive Cancer Center.
A 3-day limit on opioid prescriptions to treat surgical pain reduced the number of patients who became chronic opioid users without compromising pain relief or recovery, according to a recent study at Roswell Park Comprehensive Cancer Center.
A 3-day limit on opioid...
01/10/2023
Addiction Professional
News
09/13/2022
Tom Valentino, Digital Managing Editor
Patients who had been prescribed opioids to treat pain were found to be less likely to test positive for nonprescribed and illicit drugs, according to new research.
Patients who had been prescribed opioids to treat pain were found to be less likely to test positive for nonprescribed and illicit drugs, according to new research.
Patients who had been prescribed...
09/13/2022
Addiction Professional
News
07/20/2022
Tom Valentino, Digital Managing Editor
Findings by researchers from Ohio State University Wexner Medical Center and College of Medicine, and the University of Michigan Medical School suggest central sensitization may be a key underlying factor complicating the treatment of chronic...
Findings by researchers from Ohio State University Wexner Medical Center and College of Medicine, and the University of Michigan Medical School suggest central sensitization may be a key underlying factor complicating the treatment of chronic...
Findings by researchers from...
07/20/2022
Addiction Professional
News
07/12/2022
Tom Valentino, Digital Managing Editor
The national, not-for-profit organization’s new service will provide users with information on non-opioid pain alternatives and ways to reduce risks associated with prescribed opioids.
The national, not-for-profit organization’s new service will provide users with information on non-opioid pain alternatives and ways to reduce risks associated with prescribed opioids.
The national, not-for-profit...
07/12/2022
Addiction Professional
News
07/06/2022
Tom Valentino, Digital Managing Editor
New medications with high abuse potential are significantly more likely to make it through the development process than new medications with low abuse potential, according to a recent retrospective study by researchers from Johns Hopkins...
New medications with high abuse potential are significantly more likely to make it through the development process than new medications with low abuse potential, according to a recent retrospective study by researchers from Johns Hopkins...
New medications with high abuse...
07/06/2022
Addiction Professional

Advertisement

Advertisement